Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8267 

Contact Person: Amy Williams, NCI, Office 

of Advocacy Relations, National Cancer 

Institute, NIH, 31 Center Drive, Building 31, 

Room 10A28, Bethesda, MD 20892, (301) 

496–9723, williaam@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: NCRA: http:// 

deainfo.nci.nih.gov/advisory/ncra/ncra.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 9, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03091 Filed 2–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; High impact, 

Interdisciplinary Science in NIDDK Research 

Areas (RC2 Clinical Trial Optional): Celiac 

Disease. 

Date: March 25, 2022. 

Time: 2:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIDDK-Democracy 2, DEM 2, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Maria E. Davila-Bloom, 

Ph.D., Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 7017, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: February 8, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03055 Filed 2–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; International Research 

Fellowship Award Program of the 

National Institute on Drug Abuse 

(NIDA) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection via application 

forms, the National Institute on Drug 

Abuse (NIDA), the National Institutes of 

Health (NIH) will publish periodic 

summaries of proposed collections to be 

submitted to the Office of Management 

and Budget (OMB) for review and 

approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Dr. Lindsey Friend, Director, 

Research Training Program Officer, 

NIDA International Program, National 

Institute on Drug Abuse, National 

Institutes of Health, 3WFN MSC 6024, 

301 North Stonestreet Avenue, 

Bethesda, Maryland 20892 or call nontoll-free number (301) 402–1428 or 

Email your request, including your 

address to: lindsey.friend@nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: 

International Research Fellowship 

Award Program of the National Institute 

on Drug Abuse (NIDA), 0925–0733, 

expiration date 03/31/2022 

EXTENSION, National Institute on Drug 

Abuse (NIDA), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: These programs offer grants 

and traineeships necessary for growing 

the biomedical researcher workforce, 

and the diversity in this workforce. The 

application forms will collect 

information of applicants for selecting 

those that would benefit most 

effectively from the programs. NIDA is 

requesting approval from OMB for 

application forms to be used by these 

programs that will recruit pre-college 

through post-doctoral underrepresented 

individuals and individuals of special 

populations into the research programs 

of the Institute for research training and 

research development, for forging 

mentor/mentee relationships and 

networking between newly funded 

underrepresented researchers and 

experienced investigators funded by 

NIDA; and for a fellowship program to 

train new researchers, and support 

experienced researchers of other 

nations, in research to advance the 

biomedical and behavioral science of 

drug abuse and addiction while 

fostering multinational research in this 


jspears on DSK121TN23PROD with NOTICES1